top of page

Reporting & Project Management

Vendiagram UHP.png

Pharma & Biotech

Insurances

Patient Advocacy Groups

CRO & CMO

Approval agencies

UHP provides consulting and hands-on solutions for all phases of the product lifecycle. Through our holistic support services, we make your product a success - from Clinical Study over Early Access Programme to Launch & Market Entry Support.

UHP is in close interaction with patient advocacy groups to foster a patient-centric service design.

UHP provides the high-quality data basis for successful reimbursement negotiations. UHP's consults partners on the optimal design of the product label in preparation of a succesful commercialization.

UHP supports in the study design and execution in a clinical research setting together with CROs, CMOs and other research organizations.

UHP is well-connected with insurance companies and assist with individual reimbursement negotiations.

UHP is managing complex interactions with different stakeholders within the health system

Our support along the entire product lifecycle

11.03.2022.16-UHP.png

Clinical Development

In the clinical development phase, UHP can support with the design of the study protocol. By activating the relevant Key Opinion Leaders and research centers, we help accelerate the recruitment of suitable patients for your clinical program.

Early Access Program

We help make your medicine available to selected patients across the entire EU by organizing the launch of the Early Access Program. This includes the product import & distribution, submission of EAP dossiers and interaction with KOLs.

Commercial Roll-out

In-depth understanding of the orphan drug market and an outstanding medical network help make your product launch a success. UHP accompanies the seamless transition from EAP to commercialization and delivers high-quality data to support reimbursement negotiations for your product.

Market Penetration

Lifecycle Management

Our holistic, patient-centered services are designed to stay. Through close care, we are increasing adherence as well as long-term patient retention on therapy in the extended product lifecycle.

Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png

The market for rare disease therapies can be highly competitive and innovative treatments might face severe hurdles. UHP is there to co-design a strategy to address these challenges and help differentiate your product in the market.

Data Reporting & Real World Evidence

Along the entire value chain from manufacturer to patient's home, UHP has access to an extensive set of data points. Together with our partners, we define relevant KPIs that allow creating unique insights and improve the patient experience. Patient data is handled with the utmost care and all data reports are fully compliant with applicable data protection laws.

bottom of page